Restasis Multidose Emulsion
Product Images NDC 0023-5301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Restasis Multidose (NDC 0023-5301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Restasis Multidose 01

FDA Label Image

Restasis Multidose 02

FDA Label Image

Restasis Multidose 03

FDA Label Image

Restasis Multidose 04

FDA Label Image

Restasis Multidose 05

FDA Label Image

Restasis Multidose 06

FDA Label Image

Restasis Multidose 07

FDA Label Image

Restasis Multidose 08

FDA Label Image

Restasis Multidose 09

FDA Label Image

Restasis Multidose 0a

Restasis Multidose 0a
Not available.*
FDA Label Image

Restasis Multidose 0b

FDA Label Image

Restasis Multidose 0c

FDA Label Image

Restasis Multidose 0d

FDA Label Image

Restasis Multidose 0e

FDA Label Image

Restasis Multidose 0f

FDA Label Image

Restasis Multidose 10

FDA Label Image

Restasis Multidose 11

Restasis Multidose 11
This appears to be a label for a medication named "CONTANS At g 0055" with instructions on dosage and application. It appears to be applicable for topical use in the eyes and mentions a dosage of "vt btk." The label also indicates that the medication is only available with a prescription. The rest of the text is mostly illegible due to errors.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.